Trade Mark Journal No.2025/040 3 October 2025
WO0000001876030 (5)
Office of origin: United States of America
Date of International Registration:18 August 2025
Date of designation in the UK:
18 August 2025

International priority date claimed: 24 February 2025
(United States of America)
(99053233)
- Class 5
- Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts.
ImmunityBio, Inc.
Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA